Integer Receives Early HSR Termination for KKR Acquisition

PLANO, Texas, Sept. 30, 2026 /CourierPR/ -- Integer Holdings Corporation, a leading global medical device contract development and manufacturing organization (CDMO), has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with the pending acquisition by an affiliate of KKR. This development marks a significant step in the transaction, which was announced on August 3, 2026.

According to the terms of the definitive merger agreement, an affiliate of KKR will acquire all of the outstanding shares of Integer for $127 per share in cash. The total enterprise value of the transaction is approximately $5.7 billion. The termination of the HSR waiting period satisfies one of the conditions required for the completion of the transaction. However, the deal remains subject to approval by Integer stockholders and the satisfaction or waiver of other regulatory approvals and customary closing conditions.

Integer is scheduled to hold a virtual Special Meeting of Stockholders on October 21, 2026, at 9:00 a.m., Central Time, to vote on the merger agreement and related proposals. The meeting is open to stockholders of record as of the close of business on September 8, 2026. The Integer Board of Directors unanimously recommends that all stockholders vote "FOR" the merger agreement and other related proposals.

Integer Holdings Corporation, one of the largest medical device CDMOs in the world, serves the cardio and vascular, neuromodulation, and cardiac rhythm management markets. As a strategic partner of choice, the company advances the goals of its medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation.

The company’s annual report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 23, 2026, and the Company’s quarterly report on Form 10-Q for the fiscal quarter ended July 3, 2026, which was filed with the SEC on August 4, 2026, provide additional insights into the company’s financial and operational performance. These documents are available on the SEC’s website and on the company’s investor relations page.

Integer Holdings Corporation cautions investors and security holders that certain statements contained in this communication and other written and oral statements made from time to time by the company and its representatives are forward-looking statements. These statements are based on the company’s current expectations, and they are subject to known and unknown risks, uncertainties, and assumptions. The company’s forward-looking statements are qualified in their entirety by these cautionary factors and other important factors, many of which are beyond the company’s control, that could cause actual results to differ materially from those expressed in such forward-looking statements.